Improved Tumor Targeting with Chemically Cross - Linked Recombinant Antibody


The construction and use of recombinant chimeric and later fully humanized (CDR-grafted) antibodies to tumor-associated antigens has reduced the immune response generated to these antibodies in clinical studies. However, their long circulating half-life is a disadvantage for tumor imaging and therapy. Fragments such as F(ab')2, Fab', Fv and single chain Fv… (More)


9 Figures and Tables

Slides referencing similar topics